Maryland lawmakers have passed a plan to allow for caps on high-cost prescription drugs in the state. The legislation would empower the state’s attorney general to take action against drug manufacturers who significantly raise prices on medications deemed essential to public health. The bill was approved by the House of Delegates and the Senate, and now awaits the governor’s signature to become law.
The measure is aimed at addressing the rising costs of prescription drugs, which have become a major concern for many Maryland residents. Supporters of the bill argue that it is necessary to protect consumers from steep price hikes and ensure access to life-saving medications. Opponents, including pharmaceutical companies, argue that such measures could stifle innovation and lead to decreased availability of new drugs.
Under the new law, the state attorney general would have the authority to take legal action against drug manufacturers who raise prices by a certain percentage within a specified period of time. If the attorney general determines that a price increase is unjustified, the manufacturer could face penalties and be required to lower the price of the drug.
The legislation is part of a broader effort by Maryland lawmakers to address the rising cost of healthcare in the state. In recent years, several states have taken similar steps to regulate prescription drug prices, with mixed results. Advocates hope that the new law will serve as a model for other states looking to rein in drug costs and protect consumers.
Source
Photo credit news.google.com